ConductScience.org, home

Paper36740986

The FOXC2 Transcription Factor: A Master Regulator of Chemoresistance in Cancer.

Hargadon KM and 1 other. Technol Cancer Res Treat, 2023. Cited by 9 papers, by iCite.

Cite this record

ConductScience Library. The FOXC2 Transcription Factor: A Master Regulator of Chemoresistance in Cancer. Papers, record 36740986. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36740986

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The FOXC2 Transcription Factor: A Master Regulator of Chemoresistance in Cancer.
PubMed
Journal
Technol Cancer Res Treat
PubMed
Year
2023
PubMed
Publication types
Journal Article, Review, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
9
iCite
Relative citation ratio, by iCite
1.02
iCite
Revised in PubMed
2023-02-16
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Hargadon KMKristian Mhttps://orcid.org/0000-0002-8668-5228
2Strong EWElijah W

Source PubMed

Download CSV of authors

Topics5

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Drug Resistance, NeoplasmMajor topic
Forkhead Transcription FactorsMajor topic
NeoplasmsMajor topic
Humans
Signal Transduction

References42

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
128323030Antisense lncRNA FOXC2-AS1 promotes doxorubicin resistance in osteosarcoma by increasing the expression of FOXC2.Cancer Lett2017https://conductscience.org/library/papers/28323030PubMed
235392966Stanniocalcin 1 promotes metastasis, lipid metabolism and cisplatin chemoresistance via the FOXC2/ITGB6 signaling axis in ovarian cancer.J Exp Clin Cancer Res2022https://conductscience.org/library/papers/35392966PubMed
328397828EMT, CSCs, and drug resistance: the mechanistic link and clinical implications.Nat Rev Clin Oncol2017https://conductscience.org/library/papers/28397828PubMed
423378344FOXC2 expression links epithelial-mesenchymal transition and stem cell properties in breast cancer.Cancer Res2013https://conductscience.org/library/papers/23378344PubMed
533869020The FENDRR/FOXC2 Axis Contributes to Multidrug Resistance in Gastric Cancer and Correlates With Poor Prognosis.Front Oncol2021https://conductscience.org/library/papers/33869020PubMed
632175283RNA-seq Analysis of Wild-Type vs. FOXC2-Deficient Melanoma Cells Reveals a Role for the FOXC2 Transcription Factor in the Regulation of Multiple Oncogenic Pathways.Front Oncol2020https://conductscience.org/library/papers/32175283PubMed
731367258Hypoxia-induced feedback of HIF-1α and lncRNA-CF129 contributes to pancreatic cancer progression through stabilization of p53 protein.Theranostics2019https://conductscience.org/library/papers/31367258PubMed
832170602Foxc2 Alleviates Ox-LDL-Induced Lipid Accumulation, Inflammation, and Apoptosis of Macrophage via Regulating the Expression of Angptl2.Inflammation2020https://conductscience.org/library/papers/32170602PubMed
921507500Forkhead transcription factors: key players in health and disease.Trends Genet2011https://conductscience.org/library/papers/21507500PubMed
1026893778Downregulation of Foxc2 enhances apoptosis induced by 5-fluorouracil through activation of MAPK and AKT pathways in colorectal cancer.Oncol Lett2016https://conductscience.org/library/papers/26893778PubMed
1129577543A Forkhead Box Protein C2 Inhibitor: Targeting Epithelial-Mesenchymal Transition and Cancer Metastasis.Chembiochem2018https://conductscience.org/library/papers/29577543PubMed
1225453096Hypoxia-inducible factors are required for chemotherapy resistance of breast cancer stem cells.Proc Natl Acad Sci U S A2014https://conductscience.org/library/papers/25453096PubMed
1320460685p120-catenin is transcriptionally downregulated by FOXC2 in non-small cell lung cancer cells.Mol Cancer Res2010https://conductscience.org/library/papers/20460685PubMed
1435701636Oncogenic functions of the FOXC2 transcription factor: a hallmarks of cancer perspective.Cancer Metastasis Rev2022https://conductscience.org/library/papers/35701636PubMed
1517537911Mesenchyme Forkhead 1 (FOXC2) plays a key role in metastasis and is associated with aggressive basal-like breast cancers.Proc Natl Acad Sci U S A2007https://conductscience.org/library/papers/17537911PubMed
1631623173FOXC1 Regulation of miR-31-5p Confers Oxaliplatin Resistance by Targeting LATS2 in Colorectal Cancer.Cancers (Basel)2019https://conductscience.org/library/papers/31623173PubMed
1731659103The FOXC2 Transcription Factor Promotes Melanoma Outgrowth and Regulates Expression of Genes Associated With Drug Resistance and Interferon Responsiveness.Cancer Genomics Proteomics2019https://conductscience.org/library/papers/31659103PubMed
1835406487FOXC1 Binds Enhancers and Promotes Cisplatin Resistance in Bladder Cancer.Cancers (Basel)2022https://conductscience.org/library/papers/35406487PubMed
1926087469Areca nut contributes to oral malignancy through facilitating the conversion of cancer stem cells.Mol Carcinog2016https://conductscience.org/library/papers/26087469PubMed
2021734725Transcription factors that mediate epithelial-mesenchymal transition lead to multidrug resistance by upregulating ABC transporters.Cell Death Dis2011https://conductscience.org/library/papers/21734725PubMed

See all 42 referencesDownload CSV of references

Cited by9

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 9 citations.

PMIDTitleJournalYearIn PapersSource
42926261Generation of Functional Gene Knockout Melanoma Cell Lines by CRISPR-Cas9 Gene Editing.Methods Mol Biol2027https://conductscience.org/library/papers/42926261PubMed
42454125Out"FOX"ing cancer: the implications of FOXC2 as a putative predictive biomarker for cancer immunotherapy.Front Med (Lausanne)2026https://conductscience.org/library/papers/42454125PubMed
41755884m5C: Novel Diagnostic and Drug Repurposing Targets for Nonalcoholic Steatohepatitis.Int J Genomics2026https://conductscience.org/library/papers/41755884PubMed
41524843Fisetin-loaded Nanoemulsion and Fecal Microbiome Extract Enhance In Vitro Inhibition of Non-Small Cell Lung Cancer Progression.Cell Biochem Biophys2026https://conductscience.org/library/papers/41524843PubMed
41291552Transcription factor FOXC2 regulates miR-145/ADAMTS5 axis to inhibit angiogenesis in hepatocellular carcinoma via circular RNA 0002898.BMC Cancer2025https://conductscience.org/library/papers/41291552PubMed
40764669Wnt/ERK/CDK4/6 activation in the partial EMT state coordinates mammary cancer stemness with self-renewal and inhibition of differentiation.Br J Cancer2025https://conductscience.org/library/papers/40764669PubMed
40024963Targeting obesity, metabolic syndrome, and prostate cancer: GLP-1 agonists as emerging therapeutic agents.Discov Oncol2025https://conductscience.org/library/papers/40024963PubMed
39516331lncRNAs'p potential roles in the pathogenesis of cancer via interacting with signaling pathways; special focus on lncRNA-mediated signaling dysregulation in lung cancer.Med Oncol2024https://conductscience.org/library/papers/39516331PubMed
39473610Cancer and lymphatic marker FOXC2 drives wound healing and fibrotic tissue formation.Front Physiol2024https://conductscience.org/library/papers/39473610PubMed

Download CSV of cited by

Genes35

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ABCA321PubTator's text mininghttps://conductscience.org/library/genes/21NCBI Gene
ABCB15243PubTator's text mininghttps://conductscience.org/library/genes/5243NCBI Gene
ABCB45244PubTator's text mininghttps://conductscience.org/library/genes/5244NCBI Gene
ABCB610058PubTator's text mininghttps://conductscience.org/library/genes/10058NCBI Gene
ABCC14363PubTator's text mininghttps://conductscience.org/library/genes/4363NCBI Gene
ABCC1089845PubTator's text mininghttps://conductscience.org/library/genes/89845NCBI Gene
ABCC1185320PubTator's text mininghttps://conductscience.org/library/genes/85320NCBI Gene
ABCC1294160PubTator's text mininghttps://conductscience.org/library/genes/94160NCBI Gene
ABCC21244PubTator's text mininghttps://conductscience.org/library/genes/1244NCBI Gene
ABCC38714PubTator's text mininghttps://conductscience.org/library/genes/8714NCBI Gene
ABCC510057PubTator's text mininghttps://conductscience.org/library/genes/10057NCBI Gene
ABCC6368PubTator's text mininghttps://conductscience.org/library/genes/368NCBI Gene
ABCG29429PubTator's text mininghttps://conductscience.org/library/genes/9429NCBI Gene
BAX581PubTator's text mininghttps://conductscience.org/library/genes/581NCBI Gene
BCL2596PubTator's text mininghttps://conductscience.org/library/genes/596NCBI Gene
CASP3836PubTator's text mininghttps://conductscience.org/library/genes/836NCBI Gene
CDH1999PubTator's text mininghttps://conductscience.org/library/genes/999NCBI Gene
CDH21000PubTator's text mininghttps://conductscience.org/library/genes/1000NCBI Gene
CTNND11500PubTator's text mininghttps://conductscience.org/library/genes/1500NCBI Gene
FENDRR400550PubTator's text mininghttps://conductscience.org/library/genes/400550NCBI Gene

See all 35 genesDownload CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36740986

GET https://conductscience.org/api/papers/v1/36740986/references?page=2